• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    HeartSciences Inc. - Common Stock (NQ:HSCS)

    2.630 +0.090 (+3.54%)
    Streaming Delayed Price Updated: 9:30 AM EDT, Mar 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 593
    Open 2.630
    Bid (Size) 2.550 (1,200)
    Ask (Size) 2.630 (300)
    Prev. Close 2.540
    Today's Range 2.630 - 2.630
    52wk Range 2.010 - 6.470
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioMedNewsBreaks — HeartSciences Inc. (NASDAQ: HSCS; HSCSW) Secures UWE As Exclusive ECG Education Reference Center
    Via Investor Brand Network
    Topics Artificial Intelligence
    News headline image
    University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
    From HeartSciences Inc.
    Via GlobeNewswire

    Performance

    YTD
    -16.2%
    -16.2%
    1 Month
    -16.8%
    -16.8%
    3 Month
    +0.4%
    +0.4%
    6 Month
    -21.3%
    -21.3%
    1 Year
    -11.1%
    -11.1%

    More News

    Read More
    News headline image
    Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
    From HeartSciences Inc.
    Via GlobeNewswire
    News headline image
    HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
    From HeartSciences Inc.
    Via GlobeNewswire
    News headline image
    HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
    From HeartSciences Inc.
    Via GlobeNewswire
    News headline image
    HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1
    From HeartSciences Inc.
    Via GlobeNewswire
    News headline image
    HeartSciences Inc (NASDAQ:HSCS) Reports Q1 FY2026 Results with Narrower-Than-Expected Loss and Positive Business Updates ↗
    Via Chartmill
    News headline image
    HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results
    From HeartSciences Inc.
    Via GlobeNewswire
    News headline image
    HeartSciences Announces Conference Participation and Investor Webinar
    From HeartSciences Inc.
    Via GlobeNewswire
    News headline image
    These stocks that are showing activity before the opening bell on Friday. ↗
    Via Chartmill
    News headline image
    HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
    From HeartSciences Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream ↗
    Via Stocktwits
    News headline image
    HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
    From HeartSciences Inc.
    Via GlobeNewswire
    News headline image
    Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
    From HeartSciences Inc.
    Via GlobeNewswire
    News headline image
    HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
    From HeartSciences Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025
    From Heart Test Laboratories, Inc.
    Via GlobeNewswire
    News headline image
    HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson
    From Heart Test Laboratories, Inc.
    Via GlobeNewswire
    News headline image
    HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board
    From Heart Test Laboratories, Inc.
    Via GlobeNewswire
    News headline image
    HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program
    From Heart Test Laboratories, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is HeartSciences Inc. - Common Stock publicly traded?
    Yes, HeartSciences Inc. - Common Stock is publicly traded.
    What exchange does HeartSciences Inc. - Common Stock trade on?
    HeartSciences Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for HeartSciences Inc. - Common Stock?
    The ticker symbol for HeartSciences Inc. - Common Stock is HSCS on the Nasdaq Stock Market
    What is the current price of HeartSciences Inc. - Common Stock?
    The current price of HeartSciences Inc. - Common Stock is 2.630
    When was HeartSciences Inc. - Common Stock last traded?
    The last trade of HeartSciences Inc. - Common Stock was at 03/13/26 09:30 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.